Patent US5300779A successfully refreshed from Google Patents.
US5300779A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Capillary flow device
Assignee: Roche Diagnostics Operations Inc
•
Filing: 1992-08-18
•
Granted: 1994-04-05
•
Expires: 2012-08-18
Abstract
Abstract Novel methods and devices are provided involving at least one chamber, at least one capillary, and at least one reagent involved in a system providing for a detectable signal. As appropriate, the devices provide for measuring a sample, mixing the sample with reagents, defining a flow path, and reading the result. Of particular interest is the use of combinations of specific binding pair members which result in agglutination information, where the resulting agglutination particles may provide for changes in flow rate, light patterns of a flowing medium, or light absorption or scattering. A fabrication technique particularly suited for forming internal chambers in plastic devices is also described along with various control devices for use with the basic device.
Inventors
- 👤 Robert S. Hillman
- 👤 Michael E. Cobb
- 👤 Jimmy D. Allen
- 👤 Ian Gibbons
- 👤 Vladimir E. Ostoich
- 👤 Laura J. Winfrey
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 19:04
CPC Classifications
B; B01; B01F; B01F25/00; B01F25/40; B01F25/42; B01F25/43; B01F25/431; B01F25/4316; B01F25/433; B01F25/4338; B01F33/00; B01F33/30; B01F35/00; B01F35/71; B01F35/717; B01F35/7172; B01L; B01L3/00; B01L3/50; B01L3/502; B01L3/5027; B29; B29C; B29C65/00; B29C65/02; B29C65/08; B29C66/00; B29C66/01; B29C66/05; B29C66/302; B29C66/3022; B29C66/30223; B29C66/50; B29C66/51; B29C66/54; B29C66/70; B29C66/73; B29C66/739; B29C66/7392; B29C66/73921; G; G01; G01N; G01N21/00; G01N21/75; G01N21/77; G01N21/82; G01N33/00; G01N33/48; G01N33/483; G01N33/487; G01N33/49; G01N33/4905; G01N33/50; G01N33/86; B01F21/00; B01F2101/00; B01F2101/23; B01F23/00; B01F23/50; B01F23/56; B01L2300/00; B01L2300/06; B01L2300/0627; B01L2300/0654; B01L2300/0681; B01L2300/08; B01L2300/0809; B01L2300/0816; B01L2300/0825; B01L2300/0861; B01L2300/087; B01L2300/0887; B01L2400/00; B01L2400/04; B01L2400/0403; B01L2400/0406; B01L2400/06; B01L2400/0694; B01L3/502723; B29C45/00; B29C59/00; B29C59/16; B29C65/48; B29C65/4895; B29C66/71; B29C66/90; B29C66/95; B29C66/951; B29C66/9513; B29K; B29K2055/00; B29K2055/02; B29L; B29L2031/00; B29L2031/756; G01N15/00; G01N2015/0092; G01N15/10; G01N15/1012; G01N2015/1016; G01N21/01; G01N21/03; G01N2021/0346; G01N35/00; G01N2035/00465; G01N2035/00514; G01N21/17; G01N21/47; G01N21/49; G01N33/53; G01N33/543; G01N33/54366
Claims Analysis
Total Claims: 16
Claim 1
Independent Claim
202 words
A method for carrying out an assay that relies on measurement of coagulation time of a blood sample to determine presence or amount of an analyte in or property of said sample, which comprises: a. selecting an enclosed capillary device for use in said assay, said device comprising a housing with a capillary passageway in said housing, said capillary passageway terminating at an inlet port at one end of said passageway and a vent at another end of said passageway, said housing further being adapted to fit into an electronic monitoring device that carries out said measurement, said passageway further containing a measured amount of dry reagent on a surface of said capillary pathway that induces clotting of said blood sample; b. inserting said capillary device into said monitor; c. applying said sample to said inlet port of said device, either before or after said capillary device is inserted into said monitor; d. determining a time of coagulation of said sample using said monitor, wherein said monitor detects coagulation of said sample by detecting interaction of light with particles in said capillary passageway; and e. relating said time to said presence or amount of said analyte in or property of said sample.
Claim 2
Independent Claim
202 words
A method for carrying out an assay that relies on measurement of coagulation time of a blood sample to determine presence or amount of an analyte in or property of said sample, which comprises: a. selecting an enclosed capillary device for use in said assay, said device comprising a housing with a capillary passageway in said housing, said capillary passageway terminating at an inlet port at one end of said passageway and a vent at another end of said passageway, said housing further being adapted to fit into an electronic monitoring device that carries out said measurement, said passageway further containing a measured amount of dry reagent on a surface of said capillary pathway that induces clotting of said blood sample; b. inserting said capillary device into said monitor; c. applying said sample to said inlet port of said device, either before or after said capillary device is inserted into said monitor; d. determining a time of coagulation of said sample using said monitor, wherein said monitor detects coagulation of said sample by detecting interaction of light with particles in said capillary passageway; and e. relating said time to said presence or amount of said analyte in or property of said sample.
Claim 3
Dependent Claim
21 words
The method of claim 1, wherein said sample is whole blood or blood from which red blood cells have been removed.
Claim 4
Dependent Claim
19 words
The method of claim 1, wherein said reagent contains one or more components of a natural blood clotting mechanism.
Claim 5
Dependent Claim
10 words
The method of claim 3, wherein said reagent comprises thromboplastin.
Claim 6
Independent Claim
230 words
A method for performing a prothrombin time assay on a blood sample which comprises: a. adding said sample to an inlet port of an analytical device containing a capillary passageway used in a horizontal orientation for performing a prothrombin time assay on a blood sample, which comprises: i. a housing; ii. an inlet port in said housing; iii. a reaction chamber enclosed in said housing; iv. a capillary unit for transmitting, via capillary action, said sample from said inlet port to said reaction chamber, said inlet port, capillary unit, and reaction chamber together forming at least part of a horizontal capillary passageway when said housing is in its normal operating position; v. a measured amount of a dry reagent in said reaction chamber, wherein said reagent induces clotting of said sample; and vi. a vent for gases in said housing, said vent communicating with said reaction chamber to provide for exit of gases when sample enters said capillary passageway; b. permitting said sample to flow via capillary action from said inlet port through the capillary unit of said device into the reaction chamber; and c. detecting a change, if any, in viscosity of said sample by detecting interaction of light with particles in said capillary passageway as said sample reacts with the reagent in said capillary passageway, said change in viscosity occurring as a result of clotting of said sample.
Claim 7
Independent Claim
230 words
A method for performing a prothrombin time assay on a blood sample which comprises: a. adding said sample to an inlet port of an analytical device containing a capillary passageway used in a horizontal orientation for performing a prothrombin time assay on a blood sample, which comprises: i. a housing; ii. an inlet port in said housing; iii. a reaction chamber enclosed in said housing; iv. a capillary unit for transmitting, via capillary action, said sample from said inlet port to said reaction chamber, said inlet port, capillary unit, and reaction chamber together forming at least part of a horizontal capillary passageway when said housing is in its normal operating position; v. a measured amount of a dry reagent in said reaction chamber, wherein said reagent induces clotting of said sample; and vi. a vent for gases in said housing, said vent communicating with said reaction chamber to provide for exit of gases when sample enters said capillary passageway; b. permitting said sample to flow via capillary action from said inlet port through the capillary unit of said device into the reaction chamber; and c. detecting a change, if any, in viscosity of said sample by detecting interaction of light with particles in said capillary passageway as said sample reacts with the reagent in said capillary passageway, said change in viscosity occurring as a result of clotting of said sample.
Claim 8
Dependent Claim
192 words
An analytical system for performing a prothrombin time assay on a blood sample, which comprises: a. an electronic monitor comprising: i. means for emitting light; ii. means for detecting interaction of said light with particles in a fluid; iii. means for holding a capillary device containing a sample to be analyzed in a horizontal position so that said light interacts with said sample; b. a capillary device adapted to fit into said monitor and be retained by said means for holding, said capillary device comprising: i. a housing; ii. an inlet port in said housing; iii. a reaction chamber enclosed in said housing; iv. a capillary for transmitting, via capillary action, said sample from said inlet port to said reaction chamber, wherein said inlet port, capillary, and reaction chamber together form at least part of a horizontal capillary passageway when said housing is in its normal operating position; v. a dry reagent in said reaction chamber, wherein said reagent induces clotting of said sample; and vi. a vent for gases in said housing, said vent communicating with said reaction chamber to provide for exit of gases when sample enters said capillary passageway.
Claim 9
Dependent Claim
192 words
An analytical system for performing a prothrombin time assay on a blood sample, which comprises: a. an electronic monitor comprising: i. means for emitting light; ii. means for detecting interaction of said light with particles in a fluid; iii. means for holding a capillary device containing a sample to be analyzed in a horizontal position so that said light interacts with said sample; b. a capillary device adapted to fit into said monitor and be retained by said means for holding, said capillary device comprising: i. a housing; ii. an inlet port in said housing; iii. a reaction chamber enclosed in said housing; iv. a capillary for transmitting, via capillary action, said sample from said inlet port to said reaction chamber, wherein said inlet port, capillary, and reaction chamber together form at least part of a horizontal capillary passageway when said housing is in its normal operating position; v. a dry reagent in said reaction chamber, wherein said reagent induces clotting of said sample; and vi. a vent for gases in said housing, said vent communicating with said reaction chamber to provide for exit of gases when sample enters said capillary passageway.
Claim 10
Dependent Claim
27 words
The system of claim 6, wherein said monitor detects a change in interaction of light with particles from said sample or said reagent when said sample coagulates.
Claim 11
Dependent Claim
15 words
The system of claim 7, wherein said change is cessation of motion of said particles.
Claim 12
Dependent Claim
19 words
The system of claim 8, wherein said reagent contains one or more components of a natural blood clotting mechanism.
Claim 13
Dependent Claim
12 words
The system of claim 7, wherein said particles are red blood cells.
Claim 14
Dependent Claim
10 words
The system of claim 7, wherein said particles are metallic.
Claim 15
Dependent Claim
23 words
The system of claim 11, wherein said interaction of light is transmission, absorption, or scatter of light as light passes through said sample.
Claim 16
Dependent Claim
22 words
The system of claim 8, wherein said monitor detects when sample is applied to said capillary device and when said motion ceases.
References Cited (Backward Citations)
DE746089C
Cited
US3233975A
Cited
US3486859A
Cited
US3660836A
Cited
DE2007405A1
Cited
US3720097A
Cited
US3744975A
Cited
US3799742A
Cited
US3898982A
Cited
US3856470A
Cited
US3915644A
Cited
US3873217A
Cited
US4135819A
Cited
US3899296A
Cited
US3901658A
Cited
US4088448A
Cited
AT376300B
Cited
US3962581A
Cited
GB1529195A
Cited
US4165632A
Cited
US4011044A
Cited
US4964728A
Cited
US4244916A
Cited
US4279862A
Cited
US4233029A
Cited
US4284602A
Cited
US4492462A
Cited
US4515889A
Cited
US4876069A
Cited
DE3134611A1
Cited
US4519239A
Cited
EP0094576A1
Cited
EP0104881A2
Cited
US4690907A
Cited
US4690899A
Cited
US4777141A
Cited
US4848905A
Cited
US4756884A
Cited
US4948961A
Cited
US4963498A
Cited
US5004923A
Cited
US5140161A
Cited
US4850707A
Cited
US4849340A
Cited
US4829011A
Cited
US5039617A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-04-04 | 1997-10-04 | 1998-04-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-04-04 | 2001-10-04 | 2002-04-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-04-04 | 2005-10-04 | 2006-04-05 | $7700.00 | Window Closed / Lapsed |